Nationwide sensitivity surveillance of various antibiotic activities against bacteria isolated from patients with severe infections

Japanese Journal of Antibiotics

Volumn 54, Issue 8, 2001, Pages 401-447

  Ichiyama, S ^a   Yamaguchi, K ^a   Yamanaka, K ^a   Uehara, N ^a   Takahashi, C ^a   Kaneko, Y ^a   Mori, T ^a   Hayashi, M ^a   Kurokawa, Y ^a   Negayama, K ^a   Hirakata, Y ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFMETAZOLE; CEFOTIAM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERYTHROMYCIN; FLOMOXEF; GENTAMICIN; HABEKACIN; IMIPENEM; MEROPENEM; METICILLIN; MINOCYCLINE; OXACILLIN; PANIPENEM; PAZUFLOXACIN; PENICILLIN G; PIPERACILLIN; SULPERAZON; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CROSS RESISTANCE; DILUTION; DISEASE SEVERITY; HEALTH SURVEY; INFECTION RESISTANCE; LOWER RESPIRATORY TRACT INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; JAPAN; SEVERITY OF ILLNESS INDEX;

EID: 0034856139     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. IMP
2. Multifocal outbreaks of metallo-β-lactamase-producing Psudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems
3. More extended-spectrum β-lactamase
4. Cloning and sequencing of the gene encodeing Toho-2, a class A-β-lactamase preferentially inhibited by tazobactam
5. Cloning and sequence of the gene encodeing a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli
6. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.
7. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin and rifampin against Legionella species